Roivant Sciences Ltd. 13D and 13G filings for Immunovant, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-21 07:54 am Unchanged |
2025-04-21 | 13D | Immunovant, Inc. IMVT |
Roivant Sciences Ltd. ROIV |
96,660,341 56.900% |
0 (Unchanged) |
Filing |
| 2025-01-15 4:30 pm Purchase |
2025-01-13 | 13D | Immunovant, Inc. IMVT |
Roivant Sciences Ltd. ROIV |
96,660,341 56.900% |
16,845,010 (+21.10%) |
Filing |
| 2023-10-04 5:19 pm Purchase |
2023-10-02 | 13D | Immunovant, Inc. IMVT |
Roivant Sciences Ltd. ROIV |
79,815,331 55.300% |
6,416,667 (+8.74%) |
Filing |
| 2021-08-02 08:23 am Purchase |
2021-08-02 | 13D | Immunovant, Inc. IMVT |
Roivant Sciences Ltd. ROIV |
73,398,664 63.800% |
17,021,276 (+30.19%) |
Filing |
| 2021-03-08 08:00 am Unchanged |
2021-03-08 | 13D | Immunovant, Inc. IMVT |
Roivant Sciences Ltd. ROIV |
56,377,388 57.500% |
0 (Unchanged) |
Filing |
| 2020-09-18 4:32 pm Purchase |
2020-09-17 | 13D | Immunovant, Inc. IMVT |
Roivant Sciences Ltd. ROIV |
56,377,388 57.600% |
8,773,969 (+18.43%) |
Filing |
| 2020-09-04 5:29 pm Purchase |
2020-09-04 | 13D | Immunovant, Inc. IMVT |
Roivant Sciences Ltd. ROIV |
47,603,419 54.200% |
380,000 (+0.80%) |
Filing |
| 2020-05-14 7:24 pm Purchase |
2020-05-12 | 13D | Immunovant, Inc. IMVT |
Roivant Sciences Ltd. ROIV |
47,223,419 62.100% |
8,773,969 (+22.82%) |
Filing |